ISOFOL Isofol Medical AB (publ)
0.0976USD0.9900 SEK · STO+3.66%Mkt Cap: 31.29M USDP/E: —1d ago
Isofol Medical AB (publ) operates as a clinical stage biotech company. It develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. The company was incorporated in 2008 and is based in Gothenburg, Sweden.…